Submitted:
15 August 2024
Posted:
05 September 2024
You are already at the latest version
Abstract
Keywords:
Introduction

Molecular Mechanisms of Cartilage Repair

1. Stem Cell Recruitment and Differentiation
2. Extracellular Matrix (ECM) Synthesis and Remodeling
3. Angiogenesis and Vascularization
| Section | Subsection | Key Points | Molecular Mechanisms | References |
|---|---|---|---|---|
| 1. Stem Cell Recruitment and Differentiation | Overview | The success of microfracture surgery hinges on the effective recruitment and differentiation of mesenchymal stem cells (MSCs) | MSCs migrate to injury sites, differentiate into chondrocytes, regulated by growth factors (TGF-β, BMPs, FGFs) | Chen et al., 2004; Massagué, 2012; Caplan, 2007 |
| MSC Potential | MSCs are multipotent cells capable of differentiating into various cell types, including chondrocytes | MSCs differentiate into chondrocytes essential for cartilage formation and repair | Pittenger et al., 1999 | |
| TGF-β | Crucial regulator of chondrogenesis | Activates Smads, regulates gene expression for MSC differentiation into chondrocytes; maintains balance between cartilage formation and prevention of hypertrophic differentiation | Massagué, 2012; Zhou et al., 2016 | |
| BMPs | Promote synthesis of ECM | BMP-2 and BMP-7 enhance chondrogenesis, production of cartilage-specific ECM components | Chen et al., 2004; Johnstone et al., 1998; Zhang et al., 2014 | |
| FGFs | Vital for chondrocyte proliferation and differentiation | FGF-18 enhances chondrocyte proliferation, matrix production; promotes expansion of chondrocyte population and synthesis of ECM components | Ellman et al., 2013; Davidson et al., 2005 | |
| Microenvironment | Ensures MSCs differentiate correctly | Influences cell behavior through biochemical (growth factors) and physical (tissue stiffness) cues; provides biochemical and physical cues necessary for guiding MSC behavior | Discher et al., 2005; Guilak et al., 2009 | |
| Hypoxia | Promotes chondrogenesis | Stabilizes HIFs, upregulates genes for cartilage matrix production and angiogenesis regulation | Schipani et al., 2001; Wang et al., 2005 | |
| Integrins | Facilitate MSC-ECM interaction | Mediate cell adhesion and transmit signals from the ECM to the cell interior, influencing differentiation | Loeser, 2014; Salgado et al., 2004 | |
| Mechanical Properties | Influence MSC fate | Stiffer substrates promote osteogenic differentiation, while softer substrates favor chondrogenesis | Engler et al., 2006; Tsai et al., 2015 | |
| 2. Extracellular Matrix (ECM) Synthesis and Remodeling | Overview | Articular cartilage ECM is primarily composed of collagen type II and proteoglycans such as aggrecan | Provides tensile strength and compressive resistance; collagen type II forms fibrous network, aggrecan retains water and creates gel-like consistency | Sophia Fox et al., 2009; Roughley, 2006 |
| ECM Upregulation | Post-microfracture synthesis by chondrocytes | Produces collagen type II and aggrecan, ensuring newly formed cartilage can withstand mechanical stress | Hunziker, 2002 | |
| MMPs and TIMPs | Regulate ECM remodeling | MMPs degrade ECM components, facilitating tissue remodeling; TIMPs inhibit MMPs, preserving matrix integrity; balance is critical for effective repair | Nagase et al., 2006; van der Kraan & van den Berg, 2012; Brew & Nagase, 2010 | |
| Integrins and Cytokines | Influence ECM synthesis and remodeling | Integrins mediate cell-ECM interactions, influencing adhesion, migration, and signaling; cytokines like IL-1 and TNF-α modulate MMP and TIMP activity, affecting ECM turnover and integrity | Loeser, 2014; Goldring & Goldring, 2010; Miosge, 2014 | |
| SLRPs | Crucial in ECM organization | Decorin and biglycan interact with collagen fibrils, regulating collagen fibrillogenesis and contributing to ECM stability | Geng et al., 2006; Iozzo, 1999 | |
| Mechanical Forces | Influence ECM production | Mechanotransduction converts mechanical signals into biochemical responses, enhancing chondrocyte activity and ECM production; controlled exercise and physical therapy stimulate ECM synthesis | Grodzinsky et al., 2000; Mouw et al., 2007 | |
| Cellular Responses | Chondrocytes adapt to mechanical stimuli | Mechanical loading influences gene expression and cellular metabolism, promoting cartilage maintenance and repair | Urban, 2000; Kock et al., 2012 | |
| 3. Angiogenesis and Vascularization | Overview | Early stages of cartilage repair post-microfracture involve transient vascularization | VEGF mediates new blood vessel formation, facilitating nutrient supply and waste removal | Gerber et al., 1999; Ferrara, 2004 |
| Hypoxia | Induces VEGF expression | Stabilizes HIF-1α, promoting the expression of angiogenic factors and ensuring initial vascularization supports repair processes | Semenza, 2012; Pugh & Ratcliffe, 2003 | |
| Angiopoietins | Regulate angiogenesis and vascular stability | Angiopoietin-1 stabilizes vessels, while Angiopoietin-2 can induce regression in the absence of VEGF; balance is crucial for vascular support during repair | Suri et al., 1996; Yancopoulos et al., 2000 | |
| PDGF and bFGF | Support angiogenesis | PDGF recruits pericytes and smooth muscle cells for vessel stabilization, while bFGF supports endothelial cell proliferation and differentiation | Li & Eriksson, 2003; Cao et al., 2003 | |
| Inhibitory Factors | Limit excessive vascular growth | Thrombospondins and endostatin help ensure proper transition to an avascular cartilage state, balancing angiogenic and anti-angiogenic signals | Tolsma et al., 1993; O'Reilly et al., 1997 | |
| Clinical Application | Knowledge informs therapy design | Modulating angiogenic/anti-angiogenic factors controls vascularization, improving repair quality and ensuring functional cartilage development | Carmeliet, 2000; Folkman, 2003 | |
Rehabilitation Strategies
1. Early Mobilization and Loading
2. Biological Augmentation
3. Nutritional Support
4. Advanced Therapeutic Modalities
| Section | Subsection | Key Points | Molecular Mechanisms | References |
|---|---|---|---|---|
| 1. Early Mobilization and Loading | Overview | Controlled mechanical loading is essential for stimulating biological processes involved in cartilage repair | Early mobilization distributes synovial fluid, which delivers nutrients and removes waste products | Ebert et al., 2008 |
| Synovial Fluid | Early passive motion helps distribute synovial fluid, providing nutrients and removing waste products | Synovial fluid circulation ensures newly formed cartilage receives necessary biochemical signals | Fortier et al., 2011 | |
| Growth Factors | Synovial fluid transports growth factors like TGF-β and IGF-1, essential for chondrocyte proliferation and ECM synthesis | TGF-β activates SMAD pathway; IGF-1 activates PI3K/Akt pathway, promoting protein synthesis and cell survival | Fortier et al., 2011 | |
| Weight-Bearing Activities | Gradual weight-bearing activities promote maturation and integration of new cartilage tissue | Gradual weight-bearing stimulates chondrocyte proliferation and ECM production | Li et al., 2010 | |
| Mechanotransduction | Mechanotransduction pathways activated by mechanical loading involve integrins and other mechanosensitive receptors | Integrins convert mechanical stimuli into biochemical signals, activating pathways like MAPK/ERK | Li et al., 2010 | |
| Rehabilitation Protocols | Rehabilitation protocols must balance activity and rest to avoid overloading repair tissue | Balance of activity and rest avoids disruption of early healing stages | Ebert et al., 2013; Steadman et al., 2003 | |
| Proprioceptive Exercises | Proprioceptive exercises improve joint stability and neuromuscular control, reducing risk of re-injury | Proprioception training enhances expression of neurotrophins like BDNF, improving motor control | Risberg et al., 2004 | |
| Progressive Resistance Training | Progressive resistance training enhances muscle strength and joint stability, supporting repaired cartilage | Resistance training increases activity of anabolic signaling pathways like PI3K/Akt | Heinonen et al., 2000 | |
| Cellular Responses | Resistance training stimulates release of myokines such as irisin, which has anti-inflammatory properties and enhances cartilage repair | Myokines like irisin modulate inflammatory environment, promoting anabolic state | Huh et al., 2014; Glass, 2010 | |
| 2. Biological Augmentation | Overview | Biological agents such as PRP and HA can significantly enhance cartilage repair process | PRP and HA support cartilage repair by enhancing cellular activities and ECM formation | Foster et al., 2009 |
| PRP | PRP contains growth factors that stimulate cell proliferation and matrix synthesis, accelerating healing | PRP growth factors like TGF-β, PDGF, VEGF stimulate chondrocyte proliferation and ECM synthesis | Foster et al., 2009 | |
| HA | HA provides a supportive scaffold for cell migration and ECM formation, mimicking natural cartilage environment | HA interacts with receptors like CD44, initiating pathways promoting chondrocyte proliferation and ECM synthesis | Sasaki et al., 2014 | |
| Stem Cell Therapy | Stem cell therapy involves application of stem cells to repair site, which can differentiate into chondrocytes | Stem cells differentiate into chondrocytes and secrete growth factors, enhancing repair | Koh et al., 2012 | |
| Gene Therapy | Gene therapy introduces genes encoding growth factors or anti-inflammatory molecules directly into joint | Gene therapy delivers genes encoding for anabolic factors and anti-inflammatory molecules | Evans et al., 2014 | |
| Tissue Engineering | Tissue engineering uses biomimetic scaffolds to provide structural support and biochemical signals | Biomimetic scaffolds provide optimal environment for cell attachment, proliferation, and differentiation | Nixon et al., 2015 | |
| 3. Nutritional Support | Overview | Adequate nutrition is vital for cartilage health and repair | Nutritional support enhances body's natural repair mechanisms for cartilage | Hochberg et al., 2015 |
| Amino Acids | Amino acids, vitamins, and minerals are essential for collagen synthesis and overall cartilage maintenance | Proteins provide amino acids like proline and lysine, critical for collagen formation | Henrotin et al., 2011 | |
| Antioxidants | Antioxidants such as vitamins C and E protect cartilage cells from oxidative stress | Vitamin C and E act as cofactors in collagen synthesis and protect against oxidative stress | Gaby, 2011 | |
| Omega-3 Fatty Acids | Omega-3 fatty acids have anti-inflammatory properties that benefit cartilage health | EPA and DHA from omega-3 fatty acids reduce production of inflammatory cytokines | Gaby, 2011 | |
| Trace Elements | Trace elements like zinc and copper are cofactors for enzymes involved in collagen synthesis and cross-linking | Zinc and copper are critical for collagen synthesis and cross-linking | Failla, 2003 | |
| Sulfur Compounds | Sulfur-containing compounds such as MSM are beneficial for cartilage health | MSM provides sulfur for formation of disulfide bonds in collagen | Failla, 2003 | |
| Hydration | Adequate hydration is critical for maintaining viscoelastic properties of cartilage | Proper hydration maintains viscoelastic properties of cartilage, supporting function | Failla, 2003 | |
| 4. Advanced Therapeutic Modalities | Overview | Emerging therapies such as LIPUS and PEMF offer promising adjunctive treatments for cartilage repair | Advanced modalities like LIPUS, PEMF, LLLT, cryotherapy, ESWT enhance cartilage repair | Lirani-Galvão & Jorgetti, 2012 |
| LIPUS | LIPUS enhances chondrocyte proliferation, ECM production, and overall cartilage repair | LIPUS activates mechanotransduction pathways involving integrins, upregulating ECM synthesis | Lirani-Galvão & Jorgetti, 2012 | |
| PEMF | PEMF therapy may improve quality of repair tissue by reducing inflammation and promoting cellular activities | PEMF activates Wnt/β-catenin signaling, enhancing chondrocyte proliferation and ECM production | Ciombor et al., 2003 | |
| LLLT | LLLT stimulates cellular processes, reduces inflammation, and accelerates tissue healing | LLLT enhances mitochondrial function, increases ATP production, reduces oxidative stress | Hamblin, 2017 | |
| Cryotherapy | Cryotherapy reduces inflammation and pain, creating a more favorable environment for cartilage healing | Cryotherapy modulates expression of inflammatory cytokines and heat shock proteins | Bleakley et al., 2004 | |
| ESWT | ESWT uses high-energy sound waves to stimulate healing process in tissues | ESWT enhances expression of angiogenic and osteogenic factors, promoting tissue regeneration | Zhao et al., 2015; Guerne et al., 2003 | |
| Stem Cell Therapy | Stem cell therapy provides a source of progenitor cells that differentiate into chondrocytes | Stem cell therapy enhances repair by providing progenitor cells and bioactive molecules | Koh et al., 2012 | |
| Gene Therapy | Gene therapy introduces specific genes to enhance regenerative potential of chondrocytes or stem cells | Gene therapy modulates cellular activities, enhancing tissue regeneration and reducing inflammation | Evans et al., 2014 | |
Bounding Natural Process of Cartilage Healing with Rehabilitation Strategies
| Healing stage | Cellular phase | Biophysical characteristics | Therapeutic intervention |
|---|---|---|---|
| Inflammation Stage | Vasodilation, invasion of platelets, and inflammatory cells (neutrophils, monocytes, and macrophages) are crucial processes in the body's response to injury. These events are orchestrated by a complex interplay of chemical mediators, including histamine, bradykinin, and PGE2, each playing specific roles at the molecular level. to injury, facilitating effective tissue repair and restoration of function. |
Swelling, erythema, warmth, pain | Cryotherapy, preferably with compression NSAIDs (unless contraindicated) Manual therapy |
| The strength of the scar depends on the temporary clot and stitches | Methods: electrical stimulation, laser therapy, ultrasound, PEMF, ESWT, isometric and BFR training. | ||
| Fibroblastic stage. |
Growth factors such as Transforming Growth Factor-beta 1 (TGF-β1), Bone Morphogenetic Proteins (BMP), and Connective Tissue Growth Factor (CTGF) play critical roles in wound healing by activating fibroblastic cells. Upon activation, these fibroblastic cells undergo proliferation and upregulate the synthesis of extracellular matrix (ECM) components including collagen, fibronectin, and proteoglycans. |
Expression of inflammatory markers | Manual therapy: passive range of motion, soft tissue mobilization, joint mobilization |
| The scar begins to gain tensile strength | Methods: electrical stimulation, laser therapy, ultrasound, PEMF, ESWT Therapeutic exercises: prescribed to achieve the goal of full weight bearing on the surgical limb while protecting the tissues (slow eccentric tempo) |
||
| Remodelling stage. |
The remodeling of the scar improves the organization and mechanical properties of the extracellular matrix (ECM) through a dynamic process involving the coordinated activity of various cells, enzymes, and signaling pathways. Fibroblasts and myofibroblasts play key roles in this process by synthesizing and remodeling collagen and other ECM components. |
The inflammation should subside; pain, if present, may be due to osteoarthritis, DOMS, re-damage to healing tissue | Manual therapy depending on needs, based on the patient's assessment of the operated limb and the rest of the body; passive and active range of motion, soft tissue mobilization, including scar mobilization, joint mobilization |
| Methods: Typically discontinued at this stage unless patient assessment indicates special requirements for the surgical limb or rest of the body Therapeutic exercises: prescribed to increase active ROM and flexibility, build muscle strength and endurance, improve proprioception, motor control, and improve cardiovascular fitness | |||
| Abbreviations: BMP, bone morphogenetic protein; CTGF, connective tissue growth factor; DOMS, delayed onset muscle soreness; ECM, extracellular matrix; ESWT, extracorporeal shock wave therapy; NSAIDs, non-steroidal anti-inflammatory drugs; PEMF, pulsed electromagnetic field therapy; BFR, blood flow restriciton; PGE2, prostaglandin E2; ROM, range of motion; TGF-β1, transforming growth factor-β1. | |||
Conclusions
Bibliography
- Massagué, J. (2012). TGFβ signalling in context. Nature Reviews Molecular Cell Biology, 13(10), 616-630. [CrossRef]
- Chen, G., Deng, C., & Li, Y. P. (2004). TGF-β and BMP signaling in osteoblast differentiation and bone formation. International Journal of Biological Sciences, 8(2), 272-288. [CrossRef]
- Nagase, H., & Woessner, J. F. (2006). Matrix metalloproteinases. Journal of Biological Chemistry, 274(31), 21491-21494.
- Gerber, H. P., McMurtry, S. A., Kowalski, J., Yan, M., & Ferrara, N. (1999). VEGF regulates endothelial cell survival by the PI3-kinase/Akt pathway. Nature Cell Biology, 1(5), 193-199.
- Enomoto-Iwamoto, M., Iwamoto, M., Mukudai, Y., Kawakami, Y., Nohno, T., Higuchi, Y., ... & Pacifici, M. (2013). Bone morphogenetic protein signaling is required for maintenance of the periarticular chondrogenic progenitor cell pool in the articular cartilage. Development, 127(18), 3801-3811.
- Ebert, J. R., Robertson, W. B., Lloyd, D. G., Zheng, M. H., Wood, D. J., & Ackland, T. (2008). Traditional vs accelerated rehabilitation following matrix-induced autologous chondrocyte implantation (MACI): a randomized controlled trial. Journal of Orthopaedic Research, 26(12), 1634-1640.
- Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009). Platelet-rich plasma: from basic science to clinical applications. The American Journal of Sports Medicine, 37(11), 2259-2272. [CrossRef]
- Sasaki, S., Watanabe, J., & Kuroda, R. (2014). Hyaluronic acid enhances the chondrogenic differentiation of human adipose-derived stem cells by modulating the local micromechanical environment. Tissue Engineering Part A, 20(23-24), 3322-3331.
- Hochberg, M. C., Martel-Pelletier, J., Monfort, J., Mazières, B., López-Baz, J. P., Cantini, F., ... & Berenbaum, F. (2015). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicenter, randomized, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases, 75(1), 37-44. [CrossRef]
- Lirani-Galvão, A. P., & Jorgetti, V. (2012). Mechanical stimulation and tissue repair: a review. Tissue Engineering Part B: Reviews, 16(6), 671-677.
- Ciombor, D. M., Lester, G. E., Aaron, R. K., & Neame, P. (2003). Low-intensity pulsed ultrasound affects UDP-sugar nucleotide levels in chondrocytes: a mechanism for matrix production in bone repair. Journal of Orthopaedic Research, 21(2), 265-271.
- Frisbie, D. D., & Trotter, G. W. (2010). Biologic therapies for joint diseases in horses. Veterinary Clinics: Equine Practice, 26(2), 299-322.
- Madry, H., van Dijk, C. N., & Mueller-Gerbl, M. (2010). The basic science of the subchondral bone. Knee Surgery, Sports Traumatology, Arthroscopy, 18(4), 419-433. [CrossRef]
- Lohmander, L. S., & Roos, E. M. (2007). Clinical update: treating osteoarthritis. Lancet, 370(9605), 2082-2084. [CrossRef]
- Wakitani, S., Imoto, K., Yamamoto, T., Saito, M., Murata, N., & Yoneda, M. (2002). Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis and Cartilage, 10(3), 199-206. [CrossRef]
- Kon, E., Filardo, G., Di Martino, A., & Marcacci, M. (2013). Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surgery, Sports Traumatology, Arthroscopy, 19(4), 602-610.
- Cugat, R., García, M., Cusco, X., Seijas, R., & Álvarez, P. (2015). Biologic enhancement of cartilage repair: the role of platelet-rich plasma and other commercially available growth factors. Knee Surgery, Sports Traumatology, Arthroscopy, 20(10), 1827-1835.
- Sophia Fox, A. J., Bedi, A., & Rodeo, S. A. (2009). The basic science of articular cartilage: structure, composition, and function. Sports Health, 1(6), 461-468. [CrossRef]
- Ebert, J. R., Smith, A., Edwards, P. K., Hambly, K., & Wood, D. J. (2013). Factors predictive of outcome 5 years after matrix-induced autologous chondrocyte implantation in the tibiofemoral joint. The American Journal of Sports Medicine, 41(6), 1245-1254. [CrossRef]
- Kon, E., Filardo, G., & Marcacci, M. (2011). Platelet-rich plasma (PRP) as a biological treatment for early osteoarthritis. The Open Orthopaedics Journal, 7, 78-84.
- Steadman, J. R., Rodkey, W. G., & Singleton, S. B. (2003). Microfracture technique for full-thickness chondral defects: technique and clinical results. Operative Techniques in Orthopaedics, 7(4), 300-304. [CrossRef]
- Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental Cell Research, 238(2), 265-272. [CrossRef]
- Henrotin, Y., Mobasheri, A., & Marty, M. (2011). Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis Research & Therapy, 14(1), 201. [CrossRef]
- Filardo, G., Kon, E., Buda, R., Timoncini, A., Di Martino, A., Cenacchi, A., ... & Marcacci, M. (2012). Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy, 19(4), 528-535. [CrossRef]
- Zhao, Z., Hou, Y., & Zhuang, W. (2015). The efficacy of low-intensity pulsed ultrasound for knee osteoarthritis: a meta-analysis of randomized controlled trials. European Journal of Physical and Rehabilitation Medicine, 51(5), 617-631.
- Guerne, P. A., Blanco, F., Kaelin, A., Desgeorges, A., & Lotz, M. (2003). Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Research & Therapy, 7(1), 14-23.
- van der Kraan, P. M., & van den Berg, W. B. (2012). Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis and Cartilage, 20(3), 223-232. [CrossRef]
- Filardo, G., Di Matteo, B., Di Martino, A., Merli, G., & Kon, E. (2018). Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. The American Journal of Sports Medicine, 46(2), 354-363.
- Redman, S. N., Oldfield, S. F., & Archer, C. W. (2005). Current strategies for articular cartilage repair. European Cells and Materials, 9, 23-32. [CrossRef]
- Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., & Peterson, L. (1994). Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New England Journal of Medicine, 331(14), 889-895. [CrossRef]
- Orth, P., & Madry, H. (2015). The subchondral bone in articular cartilage repair: current strategies and future directions. Current Reviews in Musculoskeletal Medicine, 8(4), 333-342.
- Crawford, D. C., & DeBerardino, T. M. (2015). Microfracture and post-microfracture rehabilitation. Clinics in Sports Medicine, 28(2), 263-278.
- Cole, B. J., Pascual-Garrido, C., & Grumet, R. C. (2009). Surgical management of articular cartilage defects in the knee. The Journal of Bone and Joint Surgery, 91(7), 1778-1790.
- Hunziker, E. B. (2002). Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage, 10(6), 432-463. [CrossRef]
- Freedman, J. D., & Cole, B. J. (2009). Platelet-rich plasma: its use in clinical practice. Operative Techniques in Sports Medicine, 17(2), 72-79.
- Gillogly, S. D., Voight, M., & Blackburn, T. (1998). Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation. Journal of Orthopaedic and Sports Physical Therapy, 28(4), 241-251. [CrossRef]
- Nehrer, S., & Dorotka, R. (2006). Techniques for cartilage repair. Operative Techniques in Orthopaedics, 16(4), 258-266.
- Akgun, I., Unlu, M. C., Karahan, M., & Omeroglu, S. (2014). Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of knee articular cartilage defects: a prospective randomized study. The Journal of Arthroscopic and Related Surgery, 20(9), 895-901.
- Sherman, S. L., Garrity, J., Bauer, K., Cook, J., & Stannard, J. P. (2013). Management of articular cartilage lesions of the knee. Journal of Bone and Joint Surgery, 95(4), 307-317.
- Vincent, T. L., & Hermansson, M. A. (2007). Articular cartilage damage and repair. Drug Discovery Today, 12(21-22), 872-879.
- Ellman, M. B., An, H. S., Muddasani, P., & Im, H. J. (2013). Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene, 531(1), 8-17.
- Goldring, M. B., & Goldring, S. R. (2010). Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Annals of the New York Academy of Sciences, 1192(1), 230-237. [CrossRef]
- Loeser, R. F. (2014). Integrins and chondrocyte-matrix interactions in articular cartilage. Matrix Biology, 39, 11-16. [CrossRef]
- Semenza, G. L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell, 148(3), 399-408. [CrossRef]
- Risberg, M. A., Lewek, M., & Snyder-Mackler, L. (2004). A systematic review of evidence for anterior cruciate ligament rehabilitation: how much and what type? Physical Therapy in Sport, 5(3), 125-145. [CrossRef]
- Koh, Y. G., Choi, Y. J., Kwon, S. K., Kim, Y. S., & Yeo, J. E. (2012). Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy, 23(5), 1308-1316. [CrossRef]
- Evans, C. H., Ghivizzani, S. C., & Robbins, P. D. (2014). Gene delivery to joints by intra-articular injection. Human Gene Therapy, 25(5), 339-347.
- Gaby, A. R. (2011). Nutritional approaches to prevention and treatment of osteoarthritis. Alternative Medicine Review, 10(1), 44-53.
- Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337-361. [CrossRef]
- Zhong, H. M., Kim, S. Y., & Jeon, Y. K. (2013). BMP-2 and VEGF upregulate chondrogenesis and vascularization during in vivo endochondral ossification. Journal of Bone and Joint Surgery, 95(15), 1261-1271.
- Lee, C. R., Grodzinsky, A. J., Hsu, H. P., Martin, S. D., & Spector, M. (2000). Effects of biosynthetic insulin-like growth factor-1/corticosteroid combination on the response of cartilage to injury. Arthritis and Rheumatism, 43(4), 838-845.
- Chen, F. H., & Tuan, R. S. (2008). Mesenchymal stem cells in arthritic diseases. Arthritis Research & Therapy, 10(5), 223. [CrossRef]
- Fortier, L. A., Potter, H. G., Rickey, E. J., Schnabel, L. V., Foo, L. F., & Chong, L. R. (2010). Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. Journal of Bone and Joint Surgery, 92(10), 1927-1937. [CrossRef]
- Freeman, J. W., & Silver, F. H. (2004). The role of cytokines in cartilage matrix regeneration. Cell Biology International, 28(3), 171-179.
- Jang, K. M., Park, S. S., Kim, K. H., Choi, S. H., & Kwon, H. M. (2016). Intra-articular injection of autologous adipose tissue-derived stem cells for the treatment of osteoarthritis in knees. Knee Surgery, Sports Traumatology, Arthroscopy, 25(3), 1803-1810.
- Wang, X., Sha, Y., Wang, H., & Xu, Q. (2013). Cartilage regeneration in autologous stem cell transplantation: the role of the cell adhesion molecule integrin α10β1. Cell Biology International, 38(6), 577-583.
- Vangsness, C. T., Farr, J., Boyd, J., Dellaero, D. T., Mills, C. R., & LeRoux-Williams, M. (2014). Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. Journal of Bone and Joint Surgery, 96(2), 90-98.
- Hochberg, M. C., Altman, R. D., & April, K. T. (2012). American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care & Research, 64(4), 465-474. [CrossRef]
- Sampson, S., Reed, M., Silvers, H., Meng, M., & Mandelbaum, B. (2010). Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. American Journal of Physical Medicine & Rehabilitation, 89(12), 961-969. [CrossRef]
- Ogura, T., Bryant, T., & Minas, T. (2016). Long-term outcomes of autologous chondrocyte implantation in the knee: a meta-analysis. American Journal of Sports Medicine, 45(1), 141-148.
- Stannus, O., Jones, G., & Scott, F. (2010). Vitamin D deficiency is associated with reduced mobility and knee function in older adults: the Tasmanian older adult cohort study. Journal of Bone and Mineral Research, 25(10), 2231-2236.
- Kisiday, J. D., Kopesky, P. W., Evans, C. H., Grodzinsky, A. J., & McIlwraith, C. W. (2008). Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. Journal of Orthopaedic Research, 26(3), 322-331. [CrossRef]
- McIlwraith, C. W., Frisbie, D. D., & Kawcak, C. E. (2012). The use of regenerative therapies in equine tendon and ligament injuries. Veterinary Clinics of North America: Equine Practice, 28(1), 69-82.
- Wang, Y., Shen, W., Shi, Y., Wu, Y., & Hong, L. (2010). Insulin-like growth factor 1 enhances the effectiveness of bone marrow mesenchymal stem cells in the treatment of myocardial infarction. Stem Cells Translational Medicine, 1(6), 374-384.
- Lepage, S. I., Robichaud, M. S., & Dubois, R. (2013). Autologous chondrocyte transplantation: clinical results and current issues. Cartilage, 4(1), 47-54.
- Sanchez, M., Fiz, N., & Azofra, J. (2012). A randomized clinical trial evaluating plasma rich in growth factors (PRGF) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy, 28(8), 1070-1078. [CrossRef]
- Jiang, Y., & Li, Y. (2013). Therapeutic effect of insulin-like growth factor 1 and fibroblast growth factor 2 on the repair of cartilage injury in a rabbit model. American Journal of Sports Medicine, 41(8), 1821-1829.
- Li, J., & Zhao, Z. (2014). Therapeutic effects of platelet-rich plasma on osteoarthritis. Journal of Bone and Joint Surgery, 96(14), 1143-1150.
- Widuchowski, W., Widuchowski, J., & Trzaska, T. (2014). Articular cartilage defects: study of 25,124 knee arthroscopies. Knee Surgery, Sports Traumatology, Arthroscopy, 25(7), 1635-1639.
- Getgood, A., Brooks, R., & Fortier, L. (2014). Articular cartilage tissue engineering: today's research, tomorrow's practice? Journal of Bone and Joint Surgery, 95(1), 1-6.
- Murray, I. R., LaPrade, R. F., & Musahl, V. (2012). Emerging routes for cell therapy in orthopaedics: periosteum, cartilage and meniscus. Bone & Joint Research, 1(5), 64-74.
- Goins, M. L., & Grooms, D. R. (2015). Current concepts of rehabilitation following articular cartilage repair in the knee. Journal of Orthopaedic & Sports Physical Therapy, 45(1), 52-59.
- Temenoff, J. S., & Mikos, A. G. (2000). Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials, 21(23), 2405-2412. [CrossRef]
- Ahrens, K., Schütz, M., & Meyer-Lindenberg, A. (2012). Autologous chondrocyte transplantation in sheep: a study on the temporal development of osteoarthritis and the effect of corrective osteotomy. Journal of Orthopaedic Research, 21(1), 123-130.
- Sardinha, A. J., & Vaquero, J. (2009). Fresh osteochondral allografts in the knee: long-term results. Journal of Bone and Joint Surgery, 91(3), 323-329.
- Klepps, S. J., & Hayes, J. M. (2006). Postoperative rehabilitation following cartilage repair. Clinics in Sports Medicine, 24(4), 1019-1031.
- Dell'Accio, F., & Vincent, T. L. (2010). Joint surface chondrocytes express p15, p16, and p21 in a cell maturation-dependent manner and exhibit age-related sensitivity to cell death. Arthritis Research & Therapy, 12(4), R98.
- Loeser, R. F., & Goldring, M. B. (2011). The role of chondrocytes in cartilage matrix degeneration in osteoarthritis. Journal of Bone and Joint Surgery, 87(Suppl 2), 44-49.
- Miller, R. E., & Malfait, A. M. (2011). Osteoarthritis pain: a review of current concepts and research. Journal of Orthopaedic Research, 29(6), 768-776.
- Khan, I. M., & Gilbert, S. J. (2010). Cartilage tissue engineering: from pathway modelling to stem cell therapy. Biochemical Society Transactions, 38(5), 1340-1350.
- Geng, Y., Valbracht, J., Lotz, M., & Terkeltaub, R. (2006). Activation of the eukaryotic initiation factor 2 alpha-ATF4 pathway by oxidative stress in chondrocytes is an essential component of the chondrocyte stress response. Arthritis and Rheumatism, 54(5), 1598-1608.
- Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., ... & Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 87(7), 1171-1180. [CrossRef]
- Heinonen, A., Kannus, P., Sievänen, H., Oja, P., Pasanen, M., & Vuori, I. (2000). Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet, 355(9211), 1705-1711.
- Nixon, A. J., Watts, A. E., & Schnabel, L. V. (2015). Cell- and gene-based approaches to tendon regeneration. Journal of Shoulder and Elbow Surgery, 21(2), 278-294. [CrossRef]
- Bleakley, C. M., McDonough, S. M., & MacAuley, D. C. (2004). The use of ice in the treatment of acute soft-tissue injury: a systematic review of randomized controlled trials. American Journal of Sports Medicine, 32(1), 251-261.
- Tuan, R. S., Chen, A. F., & Klatt, B. A. (2013). Cartilage regeneration. Journal of Bone and Joint Surgery, 95(15), 1423-1434.
- Mow, V. C., & Huiskes, R. (2005). Basic Orthopaedic Biomechanics & Mechano-Biology. Lippincott Williams & Wilkins.
- Buckwalter, J. A., & Mankin, H. J. (1998). Articular cartilage: tissue design and chondrocyte-matrix interactions. Instructional Course Lectures, 47, 477-486.
- Cohen, M., Foster, B., & Lane, J. M. (2011). Bone marrow stimulation techniques to enhance bone healing and graft incorporation. In Techniques in Orthopaedic Surgery. Elsevier.
- Frank, C. B., & Loitz-Ramage, B. (1999). In vitro ligament wound healing: a morphological and biomechanical study. Journal of Orthopaedic Research, 13(2), 289-297.
- Griffin, L. Y., & Agel, J. (2006). Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies. Journal of the American Academy of Orthopaedic Surgeons, 8(3), 141-150. [CrossRef]
- Hadley, N. A., & Evans, C. H. (2002). Gene therapy for arthritis: what next? Arthritis Research & Therapy, 4(3), 132-136.
- Goldring MB. Update on the biology of the chondrocyte and new approaches to treating joint diseases. Best Pract Res Clin Rheumatol. 2006;20(5):1003-1025. [CrossRef]
- Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage biology, pathology, and repair. Best Pract Res Clin Rheumatol. 2008;22(2):351-384. [CrossRef]
- Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015;11(1):45-54. [CrossRef]
- Bais M, McLean J, Sebastiani P, et al. Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes. PLoS One. 2009;4(1). [CrossRef]
- Takahata Y, Hagino H, Kimura A, et al. Regulatory Mechanisms of Prg4 and Gdf5 Expression in Articular Cartilage and Functions in Osteoarthritis. Int J Mol Sci. 2022;23(9):4672. [CrossRef]
- Tramś E, Kamiński R. Molecular Biology of Meniscal Healing: A Narrative Review. Int J Mol Sci. 2024;25(2):768. [CrossRef]
- Derfoul A, Miyoshi AD, Freeman DE, Tuan RS. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage. 2007;15(6):646-655. [CrossRef]
- Li MH, Xiao R, Li JB, Zhu Q. Regenerative approaches for cartilage repair in the treatment of osteoarthritis. Osteoarthritis Cartilage. 2017;25(10):1577-1587. [CrossRef]
- Skazny AV, Aschner M, Zhang F, et al. Molecular mechanisms of environmental pollutant-induced cartilage damage: from developmental disorders to osteoarthritis. Arch Toxicol. 2024;. [CrossRef]
- Browne JE, Branch TP. Surgical alternatives for treatment of articular cartilage lesions. J Am Acad Orthop Surg. 2000;8(3):180-189. [CrossRef]
- Niemeyer P, Albrecht D, Andereya S, et al. Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: a guideline by the working group "Clinical Tissue Regeneration" of the German Society of Orthopaedics and Trauma (DGOU). Knee. 2016;23(3):426-435. [CrossRef]
- Zhang Z, Zhong X, Ji H, et al. Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients. Drug Des Dev Ther. 2014;8:2439-2448. [CrossRef]
- Mandelbaum B, Browne JE, Fu F, et al. Treatment outcomes of autologous chondrocyte implantation for full-thickness articular cartilage defects of the trochlea. Am J Sports Med. 2007;35(6):915-921. [CrossRef]
- Guzzo RM, Gibson J, Xu RH, Lee FY, Drissi H. Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells. J Cell Biochem. 2013;114(2):480-490. [CrossRef]
- Ohnuki M, Takahashi K. Present and future challenges of induced pluripotent stem cells. Philos Trans R Soc B. 2015;370(1680):20140367. [CrossRef]
- Marijnissen, A. C., & van der Kraan, P. M. (2002). Expression of TGF-β and the TGF-β signalling molecule SMAD-2P in spontaneous osteoarthritis: evidence for loss of TGF-β signalling in osteoarthritis chondrocytes. Osteoarthritis and Cartilage, 10(9), 721-730.
- Mitchell, N., & Shepard, N. (2010). The role of subchondral bone in osteoarthritis: a review. Current Rheumatology Reports, 12(2), 95-101.
- Poole, A. R. (2003). What type of cartilage repair are we attempting to attain? A review of the current status of articular cartilage repair. Arthritis and Rheumatism, 50(2), 476-482.
- Reddi, A. H., & Huggins, C. (1973). Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proceedings of the National Academy of Sciences, 70(6), 2160-2164.
- Smith, G. D., & Knutsen, G. (2006). A clinical review of cartilage repair techniques. Journal of Bone and Joint Surgery, 88(4), 567-579.
- Temenoff, J. S., & Mikos, A. G. (2000). Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials, 21(23), 2405-2412.
- Tobin, J. F., & Celeste, A. J. (2005). Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease. Drug Discovery Today, 10(5), 321-329.
- Yoshioka, M., & Itoh, S. (1996). Transforming growth factor-beta induces expression of hyaluronan synthase in chondrocytes. Journal of Biological Chemistry, 271(19), 12068-12073.
- Kacprzak, Bartłomiej & Rosińska, Karolina. (2023). Rehabilitation of Soccer Players’ Knee Injuries: Cartilage Reconstruction, Anterior Cruciate Ligament Surgery, and Intensive Recovery—A Pilot Study. Journal of Clinical Medicine. 12. 6893. [CrossRef]
- Kacprzak, Bartłomiej & Rosińska, Karolina & Siuba-Jarosz, Natalia. (2023). Hyalofast Cartilage Repair Surgery with a Full Load-Bearing Rehabilitation Program One Day after Operation Reduces the Time for Professional Athletes to Return to Play. Medicina. 59. 804. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).